Luca Issi
Stock Analyst at RBC Capital
(3.58)
# 819
Out of 5,129 analysts
218
Total ratings
48.15%
Success rate
6.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintains: Outperform | $245 → $250 | $217.80 | +14.78% | 4 | Jan 20, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $500 → $465 | $320.27 | +45.19% | 29 | Jan 20, 2026 | |
| ARGX argenx SE | Maintains: Outperform | $860 → $925 | $833.44 | +10.99% | 3 | Dec 17, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $82 → $95 | $82.72 | +14.85% | 11 | Dec 17, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $52 → $80 | $61.61 | +29.85% | 11 | Dec 11, 2025 | |
| WVE Wave Life Sciences | Upgrades: Outperform | $9 → $27 | $13.24 | +103.93% | 6 | Dec 9, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Sector Perform | $7 → $10 | $10.11 | -1.04% | 3 | Dec 8, 2025 | |
| MRNA Moderna | Maintains: Sector Perform | $28 → $25 | $38.12 | -34.42% | 18 | Nov 21, 2025 | |
| AGIO Agios Pharmaceuticals | Downgrades: Sector Perform | $57 → $28 | $26.60 | +5.26% | 1 | Nov 20, 2025 | |
| KRRO Korro Bio | Downgrades: Sector Perform | $85 → $8 | $11.85 | -32.49% | 8 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $42 → $50 | $47.25 | +5.82% | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $19 | $8.52 | +123.00% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $14 → $9 | $11.59 | -22.35% | 7 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $30 | $16.47 | +82.15% | 4 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $45 | $23.96 | +87.81% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $61 → $72 | $72.86 | -1.18% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.63 | +515.38% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $22.18 | -18.85% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $6.66 | +200.30% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.38 | +430.50% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $8.79 | +93.40% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $7.32 | +77.72% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $8.91 | +293.04% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $25.65 | +1.36% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $60.27 | +16.14% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $51.65 | +10.37% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $1.72 | +132.56% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $23.56 | +226.89% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.56 | +800.32% | 5 | Aug 7, 2024 |
Ascendis Pharma
Jan 20, 2026
Maintains: Outperform
Price Target: $245 → $250
Current: $217.80
Upside: +14.78%
Alnylam Pharmaceuticals
Jan 20, 2026
Maintains: Outperform
Price Target: $500 → $465
Current: $320.27
Upside: +45.19%
argenx SE
Dec 17, 2025
Maintains: Outperform
Price Target: $860 → $925
Current: $833.44
Upside: +10.99%
Ionis Pharmaceuticals
Dec 17, 2025
Maintains: Outperform
Price Target: $82 → $95
Current: $82.72
Upside: +14.85%
Arrowhead Pharmaceuticals
Dec 11, 2025
Maintains: Outperform
Price Target: $52 → $80
Current: $61.61
Upside: +29.85%
Wave Life Sciences
Dec 9, 2025
Upgrades: Outperform
Price Target: $9 → $27
Current: $13.24
Upside: +103.93%
Fulcrum Therapeutics
Dec 8, 2025
Maintains: Sector Perform
Price Target: $7 → $10
Current: $10.11
Upside: -1.04%
Moderna
Nov 21, 2025
Maintains: Sector Perform
Price Target: $28 → $25
Current: $38.12
Upside: -34.42%
Agios Pharmaceuticals
Nov 20, 2025
Downgrades: Sector Perform
Price Target: $57 → $28
Current: $26.60
Upside: +5.26%
Korro Bio
Nov 13, 2025
Downgrades: Sector Perform
Price Target: $85 → $8
Current: $11.85
Upside: -32.49%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $42 → $50
Current: $47.25
Upside: +5.82%
Nov 7, 2025
Maintains: Outperform
Price Target: $17 → $19
Current: $8.52
Upside: +123.00%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $14 → $9
Current: $11.59
Upside: -22.35%
Nov 6, 2025
Maintains: Outperform
Price Target: $23 → $30
Current: $16.47
Upside: +82.15%
Nov 4, 2025
Maintains: Outperform
Price Target: $65 → $45
Current: $23.96
Upside: +87.81%
Oct 28, 2025
Downgrades: Sector Perform
Price Target: $61 → $72
Current: $72.86
Upside: -1.18%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.63
Upside: +515.38%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $22.18
Upside: -18.85%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $6.66
Upside: +200.30%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.38
Upside: +430.50%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $8.79
Upside: +93.40%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $7.32
Upside: +77.72%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $8.91
Upside: +293.04%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $25.65
Upside: +1.36%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $60.27
Upside: +16.14%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $51.65
Upside: +10.37%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $1.72
Upside: +132.56%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $23.56
Upside: +226.89%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.56
Upside: +800.32%